Neptune Technologies & Bioressources(NTB - TSX V) (NEPT - NASDAQ)
Basic Shares: 48.2 million
Fully diluted: 53.9 million
*********************************
Basic Shares: 48.2 million
Fully diluted: 53.9 million
*********************************
In the wake of Versant analyst Doug Loe's much touted initiating coverage report on Neptune Technologies and its 60%-0wned subsidiary Acasti Pharma, Mr. Loe appeared on BNN today to further explain why he is recommending a "Buy" of Neptune & Acasti shares.
To view the full clip, please click here.
To view the full clip, please click here.
0 comments:
Post a Comment